Derris ovalifolia
Derris ovalifolia · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Derris ovalifolia is a unique plant species known for its distinct botanical characteristics and medicinal potential. Within its chemical profile, the presence of 7-hydroxy-6-methoxy-2H-chromen-2-one plays a significant role in its biological activity. Research suggests that this specific compound may offer therapeutic benefits when addressing various physiological challenges. In particular, the plant shows promise in its ability to manage and mitigate conditions related to inflammation. Understanding these chemical properties provides valuable insight into the plant's potential applications in pharmacology.
- Synonyms
- Millettia Ovalifolia · Pterocarpus Ovalifolius · 2 more
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Southern America
- Plant Parts
- Not available
Classification
Synonyms
Derris ovalifolia is a botanical species that has been classified under several different names throughout scientific history. Due to shifting taxonomic understandings, it is recognized by the synonym Millettia ovalifolia in various botanical records. Researchers have also identified the plant using the alternative name Phaseoloides ovalifolium. Furthermore, the species has been linked to the synonyms Pongamia ovalifolia and Pterocarpus ovalifolius in older literature. Navigating these overlapping designations is essential for accurate plant identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Derris ovalifolia is a distinctive biological entity that belongs to the vast kingdom Plantae. Within this expansive kingdom, the species is classified under the class Equisetopsida. It further follows the taxonomic order Fabales, showcasing its evolutionary connections. As a member of the family Fabaceae, it shares characteristics with a diverse group of flowering plants. Ultimately, this plant is identified by its specific genus, Derris, which defines its unique botanical identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Derris |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Derris ovalifolia is a distinctive plant species primarily found throughout the tropical regions of Asia. Its natural range extends significantly across the Indian Subcontinent, where it thrives in specific ecological niches. Within these warm, humid environments, the plant plays a unique role in the local flora of India. Understanding its specific geographic distribution helps botanists better grasp its role in the broader tropical ecosystem. Consequently, this species remains a notable element of the diverse plant life found across the subcontinent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Compounds
Derris ovalifolia, also referred to as Millettia ovalifolia, has long been utilized in traditional medicine to treat various inflammatory diseases. Recent scientific investigations into the plant's phytochemical constituents have successfully isolated the bioactive compound 7-hydroxy-6-methoxy-2H-chromen-2-one from its bark. This specific molecule has demonstrated significant inhibitory activity against lipoxygenase (LOX), providing a scientific basis for the plant's traditional medicinal uses. Through molecular docking simulations, researchers observed strong interactions between the compound and the LOX enzyme, highlighting its therapeutic potential. Consequently, 7-hydroxy-6-methoxy-2H-chromen-2-one serves as a promising lead compound for the future development of anti-inflammatory treatments.
Conditions
Derris ovalifolia, also referred to as Millettia ovalifolia, is traditionally utilized to treat a variety of diseases, specifically including inflammation. Scientific investigations into its phytochemical constituents aim to validate its medicinal use in managing inflammatory disorders. Researchers isolated the compound 7-hydroxy-6-methoxy-2H-chromen-2-one from the plant's bark to study its therapeutic potential. This specific compound demonstrated significant lipoxygenase (LOX) inhibitory activity, supporting the plant's ability to treat inflammation. Consequently, the molecular interactions identified suggest that the plant holds promise as a source for anti-inflammatory lead compounds.